MoglingBio

ImmuneAGE

This company develops a drug discovery platform for creating therapies that rejuvenate the immune system by targeting hematopoietic stem cells in the bone marrow.

HexemBio

This company develops stem cell rejuvenation therapies using synthetic environments to treat blood cancer and age-related immune decline in human patients.

Maro Bio

This biotechnology firm develops non-genotoxic conditioning agents for patients undergoing hematopoietic stem cell transplants and gene therapies.

Athernal Bio

The company develops targeted immunotherapies for patients with high-risk clonal haematopoiesis to prevent the development of blood cancers.

Neotis

This company develops immunotherapies targeting senescent cells to treat age-related and fibrotic diseases for patients with chronic conditions.

Deciduous Therapeutics

This company develops small-molecule immunotherapies that activate the immune system to remove senescent cells for patients with age-related, metabolic and fibrotic diseases.

CellRep

CellRep develops an artificial intelligence platform discovering small molecules that rejuvenate immune cells for developers of cell therapies and regenerative medicine.

Mighty Therapeutics

This company develops mitochondrial-targeted therapies for patients with rare genetic conditions like Barth syndrome and common age-related diseases.